Answers are grounded in this paper and cite their sources.
Antimicrobial photodynamic therapy offers a route to bacterial inactivation that does not depend on conventional resistance mechanisms, and methylene blue (MB) is among the most established photosensitizers. Its efficiency, however, is governed by aggregation state: only monomeric MB generates singlet oxygen efficiently, while the dimers that form within negatively charged carriers such as alginate are photodynamically inactive. Here, we report a droplet-microfluidic platform for fabricating monodisperse MB-loaded calcium alginate microgels and exploit β-cyclodextrin (β-CD) co-encapsulation to control the monomer fraction of the released dye. Internal-gelation flow-focusing produced uniform microgels (∼132 µm; coefficient of variation 2.1%), within which increasing β-CD content progressively raised the monomeric fraction of the released MB, as quantified by the A664/A610 absorbance ratio. Photosensitized ROS generation under 630 nm irradiation, measured with 1,3-diphenylisobenzofuran in a medium that preserves MB aggregation, was 1.9-fold higher for the β-cyclodextrin formulation, and the microgels produced clear, light-dependent killing of Staphylococcus aureus and Escherichia coli. β-Cyclodextrin co-encapsulation significantly enhanced bactericidal activity against S. aureus (p < 0.01), with the same trend in E. coli. By making photosensitizer monomer fraction, dose, and carrier geometry separately measurable and tunable within a single monodisperse platform, this work provides a route toward the rational optimization of photodynamic antibacterial microgels.
No takes yet. Share an insight, caveat, or question.
Abouhagger et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: